Abstract. Diabetes mellitus is a chronic disorder that affects
The prevalence of diabetes mellitus (DM) is reaching epidemic nature worldwide. In 2014 there were 422 million diabetic subjects with a more rapid increase in the incidence of type 2 diabetes (T2D) [1] . The mortality in this population is due mainly to cardiovascular diseases (CVD). The most common macrovascular complications are coronary heart disease, acute myocardial infarction (MI), stroke, peripheral vascular disease and congestive heart failure [1] .
Undiagnosed DM, as well as other glucose metabolism disturbances, is a risk factor for CVD. According to the classifi cation of the World Health Organization (WHO), there are two pre-diabetic states -Impaired fasting glycemia (IFG) and impaired glucose tolerance (IGT) [2] . The Diabetes Epidemiology Collaborative Analysis of Diagnostic Criteria in Europe study (DECODE) included 29,714 patients aged 30-89 years who were followed for a period of 11 years. The study showed that CVD risk increased with increasing blood glucose on the second hour of the oral glucose tolerance test (OGTT), and the cardiovascular mortality risk started to increase from fasting glucose levels as low as 5.25 mmol/l -well below the diabetes range [3] . In the Glucose and Myocardial Infarction (GAMI) study, an OGTT was performed in patients with acute MI and without previously detected glucose metabolism disturbances. Only 33% of the patients were normoglycemic, while 35% had IGT and 31% -undiagnosed T2D [4] . These results indicate that macrovascular complications can occur even before the diagnosis of DM is made.
The ultrasound examination is frequently used in the everyday practice as a noninvasive method for the diagnosis of CVD. Such examination tools are the transthoracic echocardiography, ultrasound measurement of intima-media thickness (IMT) of the large arteries and plaque visualization, resistive index calculation within a Doppler scan.
Transthoracic echocardiography is the method of choice for the detection of early functional and structural changes in the myocardium. Conventional methods for the examination of the left ventricle function are the two-dimensional (2D) technique, the M-mode echocardiography and pulse wave Doppler. The systolic function can be evaluated by the calculation of the ejection fraction (EF): an EF > 55% is considered to be normal; EF between 40% and 55% is slightly reduced, EF of 30-40% is moderately diminished and EF < 30% is severely impaired [5] . The pulse wave Doppler is used for measuring the velocities of the transmitral fl ow and diastolic fi lling [6] . The E-wave (E) stands for the early fi lling velocity (the period of left ventricle relaxation), and A-wave (A) is a measure of the late fi lling velocity due to the left atrial contraction. In healthy individuals E > A and the ratio E/A = 0.7-1.3. The pulse wave Doppler results depend on many factors -changes in the blood fl ow volume, the heart rate, the left atrial volume pressure.
A more accurate method is the Tissue Doppler Imaging (TDI) that can measure the velocities of contraction and elongation of different segments of the heart muscle. The mitral annulus approaches the left ventricle apex during the systole and moves away during the diastole. Thus an S'-wave is recorded (systolic wave), as well as E' and A'-waves (diastolic waves). E' (early diastolic velocity) measures the left ventricle relaxation (elongation), and A' (late diastolic velocity) determines the atrial contraction and late diastolic fi lling. The E'-wave reduction and the increase in E/E' ratio are the earliest signs of left ventricle diastolic dysfunction (LVDD) [7, 8] . Boyer et al. [9] found LVDD with the help of TDI in 63% of asymptomatic type 2 diabetes patients, while with the conventional Doppler only 46% of the individuals were determined to have dysfunction. Zahiti et al. [10] studied 300 patients, of them 150 patients non-obese with normotensive, uncomplicated T2D and 150 healthy control subjects. The conventional echocardiography showed no substantial differences in the systolic and diastolic function between the two groups. However, a lower E' velocity was detected in the T2D group with the means of TDI, and after performing a stress test, the differences between the groups became even more evident. TDI could be used routinely for the diagnosis of LVDD in patients with T2D, who are otherwise considered to have healthy hearts.
Coronary heart disease is the main cause of heart failure (HF) in type 2 diabetes patients. However, HF could be diagnosed in people with diabetes without any history of underlying ischemic heart disease, valvular disorders or hypertension. This cardiac entity is a separate disorder named diabetic cardiomyopathy (DC) [11] . DC has a multifactorial etiology, and its severity progresses in time. The main risk factors for early diastolic dysfunction are insulin resistance and hyperglycemia. The state of insulin resistance is characterized by an accelerated free fatty acid (FFA) metabolism in the myocardium which in turn is accompanied by increased oxygen consumption, reduced heart muscle effi ciency and lipotoxicity [12] . The insulin defi ciency can lead to chronic changes in the carbohydrate and lipid metabolism which cause diminished adenosine triphosphate (ATP) activity, reduced calcium uptake from the sarcoplasmic reticulum and intracellular accumulation of toxic FFA waste products. Eventually, these deteriorations induce ATP depletion, derangement in the calcium homeostasis and increased oxygen consumption from the myocardium which results in myocyte hypertrophy and apoptosis, their replacement with fi brous tissue, and fi nally -in impaired cardiac muscle contractility [13] .
The structural changes in the heart muscle lead to deterioration of the LV function. Initially, there is no clinical manifestation, but in time the disorder progresses to overt HF. These changes could be diagnosed early in the course of the disease with the help of transthoracic echocardiography. LV diastolic dysfunction (LVDD) is the earliest stage in the development of cardiomyopathy [11] . There are two mechanisms responsible for the LVDD -impaired left ventricle relaxation and decreased elasticity of the ventricular wall which are caused by the increased collagen synthesis and fi brosis accumulation. The rigid left ventricle could not be fi lled with enough blood in order to improve the stroke volume [8] .
The results of a 3-year follow up of type 2 diabetes patients without overt CVD, showed an increase from 49% to 67% in the LVDD incidence and the deterioration was mainly accounted for by age, the presence of retinopathy and the increase in the systolic blood pressure [14] . There is evidence that LVDD develops even before the onset of DM. In a study with 1063 participants, an inverse relationship between the HOMA index and E' was found, as well as positive correlation with E/E'. There was a progressive decrease in the LV diastolic function induced by the worsening of insulin resistance from individuals without metabolic syndrome (16.3% LVDD), over participants with metabolic syndrome and no diabetes (32.6%), to patients with diabetes (36.6%) [15] . There was no signifi cant difference in the LVDD incidence between the groups of non-diabetic individuals with the metabolic syndrome and type 2 diabetic patients [15, 16] . Furthermore, the participants with the two conditions had greater risk to develop dysfunction of both ventricles [16] .
Except for LVDD, other echocardiographic changes that can be found in type 2 diabetes patients [10, 17] are left ventricle remodeling and hypertrophy [18] , reduced EF [19] , dilated left atrium [19] , and valvular impairment [20] . These disorders could be diagnosed early in the course of the diabetes progression and often remain asymptomatic [19] . Jorgensen et al. found echocardiographic abnormalities in 49,8% of 1030 outpatients with DM2 and the prevailing alterations were LV hypertrophy, dilated left atrium and LVDD [19] . In the female group predominated LVDD, LV hypertrophy and increased LV mass, while in males the reduced EF was more common [19] . The researchers determined that neither the cardiac symptoms nor the clinical signs were effective to identify patients with echocardiographic abnormalities. These fi ndings suggest that every diabetic patient should undergo an ultrasound examination regardless of the lack of overt symptoms [19] . De Jong et al. studied the impact of obesity, T2D, and hypertension on the left ventricle remodeling. The echocardiographic examination showed that obesity (BMI > 30 kg/m 2 ) per se does not cause LV alterations, but when in combination with other metabolic disorders (dyslipidemia, dysglycaemia), and in these cases the concentric LV remodeling prevailed [18] . Patients with obesity and hypertension had a 4.8-fold higher incidence of concentric remodeling, and a 2-fold higher prevalence of concentric hypertrophy. The normotensive, nonobese type 2 diabetic participants had comparable changes as the normotensive individuals with obesity and metabolic disorders (concentric remodeling in 44%, concentric hypertrophy in 4%). However, when T2D was combined with obesity, regardless of the blood pressure status, the LV hypertrophy incidence increased up to 36% which is similar to the results for hypertension/obesity co-existence. Furthermore, the prevalence of a third-degree LVDD (E' < 10 cm/s'E/A ≥ 2; E/E' > 14) in both normotensive and hypertensive obesity/DM2 patients was greater than that detected in obese and T2D groups alone [18] .
Aside from HF, the E/E' ratio is also a predictor of cardiovascular events. Patients with E/E' values > 15 have three times higher relative risk of myocardial infarction and stroke than the diabetics with an E/E' ≤ 15 [21] . In their study, Bloomstrand et al., determined that E/E' is a strong predictor of myocardial infarction, comparable with HbA1c, superior to and independent of age, sex, BMI, EF, IMT, LDL-cholesterol, aortic pulse pressure velocity, the global longitudinal strain, and co-existing hypertension or CVD [21] . Mitral regurgitation also can serve as a marker of early ventricular dysfunction and overall cardiovascular death. LV remodeling causes displacement of the mitral leafl ets and deformation of the mitral annulus, which results in functional mitral regurgitation [20] . Rossi et al. found that even mild regurgitation increased 4.78-fold the risk for cardiovascular death, and patients with moderate-to-severe mitral regurgitation had 7.41-fold greater risk [20] .
There is a lot of evidence that IMT could be used as a marker for the diagnosis of asymptomatic CVD [22, 23, 24] . There is data supporting the concept that carotid atherosclerosis is an indicator of systemic atherosclerosis [25] . The 2010 American Heart Association/ American College of Cardiology (AHA/ACC) guideline point out the use of carotid IMT (cIMT) and coronary calcium score (CAC) as a class IIa recommendation for CVD risk assessment in asymptomatic adults who are at intermediate risk [22] . CIMT is measured between the intimal-luminal and the media-adventitial interfaces of the carotid artery wall [22, 26] . A value of cIMT > 1.5 mm indicates the presence of a plaque [26] . A Metaanalysis that included fi ve large-scale studies which evaluated CVD risk gave contradictory results considering the predictive value of cIMT as a marker for cardiovascular events. In this analysis, the ARIC study (Atherosclerosis Risk in Communities), CHS (Cardiovascular Health Study) and the Rotterdam study showed that cIMT could be used to assess incident CVD risk. On the other hand, in the MESA study (Multi-Ethnic Study of Atherosclerosis) the researchers found that cIMT could not predict either coronary events or stroke after adjusting for the Framingham Risk Score [22] . These contradictory fi ndings can be explained by the lack of a unifi ed protocol for cIMT measurement. The meta-analysis concluded that cIMT of the internal carotid artery and at the carotid bulb is more useful than IMT of the common carotid artery [22] . The fi rst two carotid sites are more prone to plaque formation because of the lower tangential fl ow pressure [22] . Nevertheless, the IMT assessment in these two regions is more diffi cult because it depends on the anatomical features of the particular patient and the investigator's experience [26] , and is even more complicated in obese individuals [27] .
The renal resistive index (RRI) is calculated by the following formula: (peak systolic velocity  end diastolic velocity)/peak systolic velocity [PSV-EDV/ PSV], obtained with a Doppler examination of intrarenal arteries [30] . Values of 0.47-0.70 are considered normal, and the difference between the two kidneys is about 5-8% [30] . There is data that RRI is a marker of vascular resistance as a result of atherosclerosis [31] . RI measurements depend on the pulse pressure and the artery elasticity [30] . Conditions that cause deterioration in these characteristics lead to changes in RRI respectively. For example, in newly diagnosed T2D patients there is a much higher RRI in comparison to healthy controls and patients with hypertension. After nitroglycerin intake, the RRI reduction in the diabetic group is to a much less extent compared to the hypertensive and control groups which means that there is greater vascular damage in diabetes [32] . In T2D patients higher RRI values could be found even before the presentation of proteinuria and with both normal or increased glomerular fi ltration rates [33] , whereas the difference between diabetes patients and healthy individuals disappears in high degree renal insuffi ciency (eGFR < 30 ml/min/1.73 m 2 ) [30] . In their study, MacIsaac et al. found that RRI is signifi cantly higher in type 2 diabetes patients with ultrasound data for LVDD (RI 0.72 ± 0.06) in comparison to the participants with normal echocardiography (RI 0.66 ± 0.06, p < 0.001) [34] . There is a positive relationship between RRI, LVDD and left ventricle fi lling pressure. These fi ndings support the hypothesis that vascular and myocardial stiffening in diabetes are manifestations of common pathophysiological mechanisms [34] . RRI can be used as a marker of early renal impairment and atherosclerosis of the intrarenal arteries in people with diabetes.
The carotid RI is a predictor of cardiovascular morbidity and mortality, and the correlation between RI and the risk of CVD is comparable to the correlation between the carotid IMT and the risk of cardiovascular events [35, 36] . Changes in the carotid elasticity could be detected by RI calculation even in cases of seemingly normal ultrasound imaging, without any changes in IMT [36] . The Doppler-derived markers, such as the higher RI, lower peak systolic and end diastolic velocities, correlate with the incident cardiovascular risk [37] . Furthermore, there is evidence that the end diastolic velocity is an independent risk factor for CVD [37] . Kinouchi et al. found that the presence of T2D, but not the HbA1c level, is correlated with higher common carotid artery RI values [35] .
In conclusion, type 2 diabetes patients are more exposed to acute cardiovascular events and heart failure, and their cardiovascular risk shows a positive correlation with the rise of the blood glucose levels. The ultrasound examination is a noninvasive, fast and easy method for direct visualization of the myocardial and vascular damages. Transthoracic echocardiography and tissue Doppler imaging help in detecting the earliest signs of myocardial structural and functional deterioration, while the measurements of IMT, the renal and carotid RI could be helpful in assessing the presence of systemic atherosclerosis. With the help of these diagnostic tools could often be found signs of CVD in asymptomatic diabetes patients, which makes them an irreplaceable aid in the screening for macrovascular complications in T2D.
